‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌
OCT has become indispensable.
ZEISS OCT
Am I prepared for new Dry AMD therapies?
Your ZEISS CIRRUS has all you need to diagnose and manage Geographic Atrophy in Dry AMD patients.

CIRRUS® from ZEISS is loaded with Advanced RPE Analysis*, which allows you to assess the integrity of the RPE and how it may have changed.

OCT has become indispensable. Learn how CIRRUS OCT with Advanced RPE Analysis can benefit your practice and assist you with the management of your patients.
*Not available on ZEISS CIRRUS 500 model
en-INT_31_030_0155I
Imprint
Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52
07745 Jena, Germany
Phone: +49 3641 220-0
Local court Jena, HRB 205623
USt-IdNr. DE 811 922 737

Management board of the Carl Zeiss Meditec AG:
Dr. Markus Weber (President & CEO), Justus Felix Wehmer (CFO)

Chairman of the supervisory board:
Dr. Karl Lamprecht